Real-time enrollment status for this breast cancer early stage breast cancer (stage 1-3) clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 5:39 PM UTC
| NCT Number | NCT06917313 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer Early Stage Breast Cancer (Stage 1-3) |
| Phase | PHASE2 |
| Target Enrollment | 92 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Yale University |
| Last Updated on CT.gov | June 2, 2026 (Jun 2, 2026) |
As of July 17, 2026: Clinical trial NCT06917313 is currently recruiting participants. This phase2 study for breast cancer early stage breast cancer (stage 1-3) is actively seeking new participants at 2 locations across the United States. The study is sponsored by Yale University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06917313 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06917313 was last updated Jun 2, 2026 (June 2, 2026). HelloStudys verifies this status automatically.